Moderna This Year: Outperforming Vaccine Stocks So Far
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Investors follow market indices to gauge performance, set expectations, and benchmark risk. Indices provide a common frame for evaluating results.
28,426 articlesModerna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
The SEC has approved a slate of spot XRP ETFs, opening direct XRP exposure for retail and institutional investors wit...
Investors relying on monthly income from the Vanguard Intermediate-Term Corporate Bond Index Fund ETF are evaluating ...
As Rivian gears up for the upcoming earnings release, two major catalysts could shape the stock's trajectory. This gu...
JEPI investors missed 13.21% gains in a strong market as an options overlay muted upside and taxes eroded income. Thi...
As AI workloads push data-center networks to the limit, Ciena could be uniquely positioned to turn a hidden opportuni...
Six years after Bitcoin endured its COVID-era collapse, the market has staged a dramatic rebound. This piece examines...
Analysts project NVIDIA’s free cash flow to climb sharply as AI deployments accelerate, potentially changing how inve...
As market yields shift, a growing cohort of investors turning $400,000 into passive income is using Delaware Statutor...
Starlink could change how we buy internet and phone services, and SpaceX's IPO adds a new layer of opportunity and ri...
Insider moves often raise questions for investors. This piece breaks down what Arteris CEO's stock sale could mean, h...
Investors face a pivotal test of yield durability in BIZD and PBDC as rate dynamics and NAV trends threaten tradition...